Transcription of KDIGO 2016 CLINICAL PRACTICE GUIDELINE …
{{id}} {{{paragraph}}}
KDIGO 2016 CLINICAL PRACTICE GUIDELINE UPDATE ON DIAGNOSIS, EVALUATION, PREVENTION AND TREATMENT OF CKD-MBD PUBLIC REVIEW DRAFT AUGUST 2016 ii TABLE OF CONTENTS iii Work Group iv KDIGO Executive vi Reference vii CKD viii Conversion ix Abbreviations and x 1 Summary and Comparison of 2016 Updated and 2009 KDIGO CKD-MBD 2 Chapter : Diagnosis of CKD MBD: 7 Chapter : Treatment of CKD MBD Targeted at Lowering High Serum Phosphorus and Maintaining Serum 12 Chapter : Treatment of Abnormal PTH levels in CKD 24 Chapter : Treatment of Bone with Bisphosphonates, Other Osteoporosis Medications, and Growth 31 Chapter 5: Evaluation and Treatment of Kidney Transplant Bone 32 Appendix: Methodologic Approach to the 2016 KDIGO CKD-MBD 34 45 iii DISCLAIMER SECTION I: USE OF THE CLINICAL PRACTICE GUIDELINE This CLINICAL PRACTICE GUIDELINE U
kdigo 2016 clinical practice guideline update on diagnosis, evaluation, prevention and treatment of ckd-mbd public review draft august 2016
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
KDOQI CLINICAL PRACTICE GUIDELINE AND, Kdoqi clinical practice guideline and clinical practice, Clinical practice guideline, Clinical, KDIGO Clinical Practice Guideline for Lipid Management, Sucrose Administration, Clinical Practice, Medication Guidelines for Obstetrics and, Medication Guidelines for Obstetrics and Gynaecology, Management of Chronic Kidney, Staging, Chronic, Chronic kidney